Search

Search Constraints

You searched for: Author/Creator Labianca, Roberto

Search Results

11. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials. Issue 12 (December 2020)

12. Ethics in Oncology: Principles and Responsibilities Declared in the Italian Ragusa Statement. Issue 6 (November 2016)

13. Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative. (May 2020)

14. Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study. Issue 140 (April 2016)

15. Hypercoagulation screening as an innovative tool for risk assessment, early diagnosis and prognosis in cancer: the HYPERCAN study. Issue 140 (April 2016)

16. Impact of diabetes and metformin use on recurrence and outcome in stage II–III colon cancer patients—A pooled analysis of three adjuvant trials. (May 2022)

17. Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial. (January 2020)

18. MicroRNA‐425‐3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma. (21st July 2014)

19. Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer – A GISCAD phase II randomized trial. (May 2021)

20. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. (May 2021)